• DMG-PEG2000-NH2: A Design Guide for TB Delivery

  2026-09-05

  DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid-platform engineering with rational antimycobacterial assay design. This guide explains its amide-coupling chemistry, formulation role, practical controls, and the translational limits of applying sulfonamide SAR insights to advanced delivery systems.

• Laminin (925-933): Practical Assay Guide

  2026-09-04

  This guide explains how to use Laminin (925-933) as a defined cell adhesion peptide in attachment, migration, and chemotaxis workflows. It focuses on product-dossier parameters, assay controls, solution handling, and interpretation limits; it should not be treated as evidence of broad therapeutic, in vivo, or metastasis-inhibitory activity.

• Phosphorylation as a Gatekeeper of BMAL1 Condensates

  2026-09-04

  BMAL1 phase separation links phosphorylation state to circadian transcription, creating a compelling use case for orthogonal dephosphorylation controls. This thought-leadership guide explains how Lambda Protein Phosphatase (RNase-free) can help translational researchers distinguish phosphorylation-dependent biology from antibody, protein integrity, and condensate-assay artifacts.

• RAFT Cationic Polymers for mRNA Delivery

  2026-09-04

  This study combines combinatorial RAFT polymerization, high-throughput biological screening, and machine learning to identify tertiary amine-containing methacrylate polymers for mRNA delivery. Its main contribution is a data-driven framework linking polymer and polyplex attributes with uptake, cytotoxicity, and transfection performance, while also highlighting the need for experimental validation of computational design rules.

• How to Measure Cancer Drug Responses In Vitro

  2026-09-03

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of anticancer drug response. This framework supports better assay design, endpoint selection, and interpretation of time-dependent drug effects in cancer biology and mechanistic inhibitor studies.

• Gut Microbiota, RPE/Choroid, and AMD Pathobiology

  2026-09-02

  The 2022 reference study connects the absence of gut microbiota with RPE/choroid transcriptomic changes, smaller laser-induced choroidal neovascularization lesions, and reduced microglial infiltration in mice. Its combined RNA-sequencing and ocular angiogenesis model provides evidence for a gut–RPE/choroidal axis while also illustrating the RNA-to-cDNA workflow demands of transcriptomic research.

• CD8+ T Cell Metabolic Flexibility via CD28–ARS2

  2026-09-02

  The reference study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and enables activated CD8+ T cells to adjust glucose catabolism. Its findings separate this splicing mechanism from canonical CD28–PI3K signaling and connect PKM2 enrichment with interferon-γ production and antitumor effector activity.

• Protein A/G Magnetic Beads: Practical Guide

  2026-09-01

  Protein A/G Magnetic Beads (K1305) provide Fc-directed capture of IgG antibodies for antibody purification, immunoprecipitation, co-IP, and Ch-IP workflows from complex biological samples. They should be used as research-use affinity particles, with antibody compatibility, bead loading, wash conditions, and elution conditions optimized for each assay rather than assumed from a universal protocol.

• Phosbind Biotin LC: PVDF Workflow Guide

  2026-09-01

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes using streptavidin-HRP and chemiluminescence. It is suited to Western Blot phosphorylated protein detection, but not to aqueous-only workflows, long-term storage of prepared solutions, or residue-specific phosphorylation assignments.

• Pifithrin-α (PFTα): A p53 Inhibitor Guide

  2026-08-31

  Pifithrin-α is a p53 inhibitor used to test p53-dependent apoptosis, growth arrest, and ferroptosis mechanisms. This guide connects product handling with evidence from a maternal deltamethrin neurotoxicity study while defining preclinical limits.

• NADH: Reduced Nicotinamide Adenine Dinucleotide

  2026-08-31

  NADH, or reduced nicotinamide adenine dinucleotide, is an electron-carrying coenzyme that connects glycolytic and tricarboxylic-acid-cycle metabolism with mitochondrial ATP production. Its research value depends on compartment, redox context, assay conditions, and careful separation of NADH effects from NAD+-dependent signaling.

• SETD7 Depletion Promotes White Fat Browning

  2026-08-30

  This study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis and links its depletion to an Adcy7–Sirt1–CREB1 signaling axis. The findings provide a mechanistic framework for studying adipose browning and metabolic protection in obese mice, while also highlighting important limits for translation to human metabolic disease.

• Medroxyprogesterone Acetate in Decidualization Assays

  2026-08-29

  Explore how Medroxyprogesterone acetate and MPA can be used as receptor-aware perturbations in endometrial decidualization research. This guide translates vitamin D/VDR findings into practical assay decisions while clearly separating validated evidence from exploratory applications.

• Bradykinin B2 Receptors and Ileal Peristalsis

  2026-08-28

  Chan and Rudd showed that bradykinin suppresses the peristaltic reflex in the isolated guinea pig ileum through pharmacologically defined B2 receptors, rather than B1 receptors. The study establishes a quantitative ex vivo framework for linking kinin receptor signaling to intestinal propulsion and clarifies how agonist, antagonist, and comparator responses can be interpreted.

• CRISPR/Cas9 mRNA–gRNA Editing of LGMN

  2026-08-28

  This study developed a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNA to disrupt LGMN, a lysosomal protease associated with aggressive breast cancer behavior. The work links an in vitro transcription-based RNA production workflow with reduced lysosomal/autophagic degradation, migration, invasion, and experimental lung metastasis, while also highlighting the preclinical limitations of this approach.

8831 records 7/589 page Previous Next First page 上5页 678910 下5页 Last page